AUPH R&D Expenses
Aurinia Pharmaceuticals Inc · R&D Expenses
AUPH R&D Expenses
Latest reported$13.05Mperiod ending
AUPH Quarterly R&D Expenses ($0.00 → $13.05M)
Quarterly R&D Expenses
High-resolution chart · PNG
AUPH r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 13,050,000 | |
| 7,470,000 | |
| 10,895,000 | |
| 8,435,000 | |
| 7,432,000 | |
| 5,743,000 | |
| 8,107,000 | |
| 3,047,000 | |
| 4,080,000 | |
| 5,551,000 | |
| 10,228,000 | |
| 13,605,000 | |
| 12,650,000 | |
| 13,158,000 | |
| 9,870,000 | |
| 10,973,000 | |
| 11,525,000 | |
| 12,620,000 | |
| 11,149,000 | |
| 20,066,000 | |
| 10,091,000 | |
| 9,833,000 | |
| 13,173,000 | |
| 12,243,000 | |
| 11,076,000 | |
| 13,835,000 | |
| 13,292,000 | |
| 17,791,000 | |
| 11,152,000 | |
| 10,631,000 | |
| 10,839,000 | |
| 11,152,000 | |
| 10,504,000 | |
| 8,887,000 | |
| 8,691,000 | |
| 10,807,000 | |
| 7,107,000 | |
| 7,325,000 | |
| 5,462,000 | |
| 3,342,000 | |
| 2,406,000 | |
| 3,324,000 | |
| 3,652,000 | |
| 4,670,000 | |
| 4,330,000 | |
| 3,330,000 | |
| 3,092,000 | |
| 2,433,000 | |
| 2,547,000 | |
| 1,040,000 | |
| 640,589 | |
| 527,346 | |
| 429,592 | |
| 332,203 | |
| 3,301,711 | |
| 562,865 | |
| 803,264 | |
| 803,840 | |
| 939,625 | |
| 742,989 | |
| 1,115,103 | |
| 803,572 | |
| 968,427 | |
| 671,641 | |
| 970,496 | |
| 1,391,014 | |
| 2,159,982 | |
| 1,720,460 | |
| 1,387,656 | |
| 1,916,528 | |
| 1,093,374 | |
| 2,944,454 | |
| 3,950,677 | |
| 3,709,317 | |
| 7,622,121 | |
| 6,661,966 | |
| 8,259,276 | |
| 5,644,070 | |
| 4,714,138 | |
| 5,014,329 | |
| 4,818,704 | |
| 4,278,606 | |
| 4,522,691 | |
| 5,079,774 | |
| 4,993,306 | |
| 4,403,571 | |
| 5,490,337 | |
| 4,923,921 | |
| 1,177,653 | |
| 1,789,936 | |
| 3,150,076 | |
| 1,967,947 | |
| 1,952,515 | |
| 1,898,104 | |
| -3,609,508 | |
| 2,672,253 | |
| 4,906,693 | |
| 3,338,140 | |
| 1,733,272 | |
| 2,691,997 |